glp-1 vs gip-1 The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Frontiers | Mechanisms of action

A meta-analysis of 37 RCTs found that testosterone therapy reduced total body fat by an average of 1.6 kg and increased lean mass by 1.6 kg

K.SeshaiahK.ReddyA

Further down the intestinal tract, GSH levels in digesta were significantly higher in the HGSH group as compared to the LGSH group

Cost-effectiveness of obesity treatments: glucagon-like peptide-1 receptor agonists, endoscopic sleeve gastroplasty, and metabolic/bariatric surgery

Abbreviations AHI: Apnea-Hypopnea Index CV: Cardiovascular ETD: Estimated Treatment Difference HFpEF: Heart Failure with Preserved Ejection Fraction MACE: Major Adverse Cardiovascular Events MASLD: Metabolic-Associated Steatotic Liver Disease MASH: Metabolic-Associated Steatohepatitis OA: Osteoarthritis QOL: Quality of Life RRR: Relative Risk Reduction (1-Hazard Ratio) References Apovian CM